- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Govitecan for mUC, Enfortumab Vedotin for Advanced UC, Bladder Sparing Treatment
63 views
July 22, 2021
Comments 0
Login to view comments.
Click here to Login
2021 Virtual KU Hematology and Medical Oncology Review